Immune globulin injection is effective for patients with new crown

"Frontiers in Immunology" magazine recently published the results of a multi-center retrospective study of the treatment plan for patients with severe new coronary pneumonia from the team of Professor Li Taisheng, director of the Department of Infectious Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences.

"Last year, we have reported three cases of successful treatment of patients with severe new coronary pneumonia by high-dose intravenous immunoglobulin, but there is still a lack of evidence for a larger series of cases.

Li Taisheng pointed out that for mild and common patients, symptomatic support and close monitoring may be the most important treatment.

In addition, Li Taisheng introduced that previous studies have shown that severely ill patients with Middle East respiratory syndrome, influenza, and respiratory syncytial virus-related lower respiratory tract infections all have excessive immune activation and immune-mediated pathological damage in their bodies.